Financials

  • Market Capitalization 79.71 M
  • Employee 16
  • Founded N/A
  • CEO Chris Giordano
  • Website www.tenaxthera.com
  • Headquarter Delaware, United States
  • FIGI BBG000BJ6R36
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4023
GOSS
Gossamer Bio, Inc. - Common Stock
0.17 USD0.00%+13.33%-19.05%-92.98%83.10 M USD
4052
MAIA
MAIA Biotechnology, Inc. Common Stock
1.32 USD-5.04%-2.94%+10.92%-36.54%80.29 M USD
4064
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.14 USD-4.20%+0.88%-6.56%-12.31%78.40 M USD
4068
CING
Cingulate Inc. - Common Stock
5.33 USD-2.02%-3.27%+17.66%-13.47%77.51 M USD

Frequently asked questions about Tenax Therapeutics, Inc.

What is the Tenax Therapeutics, Inc. stock price today?

The current price of Tenax Therapeutics, Inc. (TENX) is 2.13. Over the past 24 hours, the stock has changed by -2.74%. Follow the TENX chart for real-time price dynamics.

What is the stock ticker of Tenax Therapeutics, Inc.?

Tenax Therapeutics, Inc. trades under the ticker TENX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Tenax Therapeutics, Inc. stock going up?

TENX has changed by +25.29% over the last week, -85.70% over the last month, and -71.79% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Tenax Therapeutics, Inc.?

Tenax Therapeutics, Inc. currently has a market capitalization of 79.71 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Tenax Therapeutics, Inc. earnings last quarter?

Last quarter, Tenax Therapeutics, Inc. reported earnings of -0.35 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Tenax Therapeutics, Inc. revenue for the last quarter?

Tenax Therapeutics, Inc. reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Tenax Therapeutics, Inc. net income for the last quarter?

Tenax Therapeutics, Inc. reported net income of -17.8 M for the last quarter. The previous quarter showed -15.72 M, which means net income changed by -13.28%.

How many employees does Tenax Therapeutics, Inc. have?

As of the latest available data, Tenax Therapeutics, Inc. has 16 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Tenax Therapeutics, Inc. stock?

You can buy Tenax Therapeutics, Inc. (TENX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Tenax Therapeutics, Inc. stock?

Investing in Tenax Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TENX chart and related analysis on metatrader.com as part of your research.

News